Pacira Biosciences, Inc. (PCRX)
24.77
+0.35
(+1.43%)
USD |
NASDAQ |
Dec 09, 16:00
24.75
-0.02
(-0.08%)
After-Hours: 20:00
Pacira Biosciences Shareholders Equity (Quarterly): 727.21M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Hologic, Inc. | 5.048B |
| CorMedix, Inc. | 374.13M |
| ADMA Biologics, Inc. | 431.19M |
| Atara Biotherapeutics, Inc. | -36.63M |
| AnaptysBio, Inc. | -29.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.298B |
| Total Liabilities (Quarterly) | 570.36M |
| Debt to Equity Ratio | 0.5848 |
| Current Ratio | 5.256 |
| Net Debt Paydown Yield | 4.03% |